CareDx, Inc.
CDNA· Nasdaq
CDNACareDx, Inc.
Source filing unavailable
| Metric | Q2 2014 | Q2 2013 |
|---|---|---|
| Revenue | $6.78M | $5.46M |
| Net Income | $877.00K | -$802.00K |
| EPS Diluted | $0.13 | -$0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
